Use of a chemically-stabilized chlorite matrix for the parentera

Details Use of a chemically-stabilized chlorite matrix for the parentera Use of a chemically-stabilized chlorite matrix for the parentera

1993-03-19

2000-07-11

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Boron

424665, A61K 3322, A61K 3314

Patent

active

060869224

ABSTRACT:
The present invention is concerned with the use of a chemically-stabilized chlorite matrix for the parenteral treatment of HIV infections. The chlorite matrix is an isotonic solution containing 5 to 100 mMol ClO.sub.2- per liter of solution.

REFERENCES:
patent: 4296103 (1981-10-01), Laso
patent: 4507285 (1985-03-01), Kuhne
patent: 4725437 (1988-02-01), Kuhne
patent: 5019402 (1991-05-01), Kross et al.
Mar. Index 10.sup.th Ed # 4865 1983.

Affiliated with

Also associated with

Rating

Use of a chemically-stabilized chlorite matrix for the parentera does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a chemically-stabilized chlorite matrix for the parentera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a chemically-stabilized chlorite matrix for the parentera will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-539532